机构地区:[1]北京大学第六医院公共卫生事业部北京大学精神卫生研究所国家卫生健康委员会精神卫生学重点实验室(北京大学)国家精神心理疾病临床医学研究中心(北京大学第六医院),100191 [2]北京大学第六医院临床精神病学研究室北京大学精神卫生研究所国家卫生健康委员会精神卫生学重点实验室(北京大学)国家精神心理疾病临床医学研究中心(北京大学第六医院),100191 [3]北京大学第六医院北京大学精神卫生研究所国家卫生健康委员会精神卫生学重点实验室(北京大学)国家精神心理疾病临床医学研究中心(北京大学第六医院),100191
出 处:《中华精神科杂志》2020年第5期438-445,共8页Chinese Journal of Psychiatry
摘 要:目的分析2018年全国严重精神障碍患者管理治疗情况,并与2014—2017年比较相关指标的变化,为政府决策提供依据。方法采用描述性分析方法,对2011年8月1日至2018年12月31日全国及各省(自治区、直辖市)国家严重精神障碍信息系统使用情况以及患者登记、管理、治疗情况等进行分析。结果截至2018年底,全国2832个区县(99.23%,2832/2854)使用信息系统。全国在册患者5994054例,报告患病率0.43%(5994054/1379837956);在管患者5688164例,管理率94.90%(5688164/5994054),规范管理患者4956545例,规范管理率82.69%(4956545/5994054);服药患者4873322例,服药率81.30%(4873322/5994054),规律服药患者2504323例,规律服药率41.78%(2504323/5994054);病情稳定患者4426558例,病情稳定率80.60%(4426558/5492261)。病情稳定率与管理率、规范管理率、服药率、规律服药率呈正相关(r分别为0.509、0.695、0.403、0.539,均P<0.05)。与2017年相比,在册患者增加187702例,管理率、规范管理率、服药率、规律服药率、病情稳定率分别增加2.24%、7.84%、11.80%、7.13%、5.59%。2018年登记的精神分裂症、偏执性精神病、分裂情感性精神病、双相情感障碍、癫痫所致精神障碍、精神发育迟滞伴发精神障碍患者未治期分别为3.54、4.61、2.73、3.18、5.35、13.34年,分裂情感性精神病和精神发育迟滞伴发精神障碍患者未治期短于2017年。结论2018年国家严重精神障碍信息系统覆盖范围继续扩大,登记患者人数持续增长,患者管理和服药水平有所提高。Objective To analyze the management and treatment situation for patients with psychosis in China in 2018,and compare with those in 2014-2017,in order to provide a reference for policy making and services delivering.Methods Descriptive method was used to analyze the system usage and registration,management and treatment situation of the patients with psychosis,using the data obtained from“National Information System for Psychosis”in China and all provinces(municipalities,autonomous regions),date traced from 1st August 2011 to 31st December 2018.Results By the end of 2018,the information system was adapted by 2832 districts/counties,accounting for 99.23%of the total county-level administrative areas(2832/2854).5994054 patients were registered,and registered rate was 0.43%(5994054/1379837956).In 2018,5688164 patients were provided with follow-up services by primary health care staffs,and the management rate was 94.90%(5688164/5994054).4956545 patients were followed up regularly,with the regular management rate of 82.69%(4956545/5994054).Moreover,4873322 patients were treated by taking antipsychotics,with the medication-taking rate of 81.30%(4873322/5994054),and 2504323 patients took medication regularly,with the regular medication-taking rate of 41.78%(2504323/5994054);4426558 patients were in stable condition and the stability rate was 80.60%(4426558/5492261),which was positively correlated with the follow-up rate,regular follow-up rate,medication-taking rate and regular medication-taking rate(r=0.509,0.695,0.403,0.539,all P<0.05).Comparing with 2017,there were 187702 more registered patients in 2018 and all indicators above were higher in 2018.Duration of untreated schizophrenia,bipolar disorder,delusional disorder,schizoaffective disorder,psychotic disorder with epilepsy,mental retardation with psychotic symptoms were 3.54,4.61,2.73,3.18,5.35,13.34 years respectively,and the duration of untreated delusional disorder and mental retardation with psychotic symptoms were shorter than those in 2017.Conclusion Serv
分 类 号:R749[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...